A 10-year rally in U.S. home prices could be coming to an end, says Yale’s Robert Shiller
A decade-long rally in U.S. home prices could finally come to an end once the Federal Reserve stops its rate-hiking cycle, said the professor of economics.
Chevron appoints Eimear Bonner as new finance chief and issues preliminary second-quarter earnings results
Chevron, the second-largest U.S. oil firm, reported second-quarter earnings late Sunday and announced plans for CFO Pierre Breber to retire in 2024.
U.S. needs to go ‘further and faster’ to achieve climate goals, lawmakers say
As extreme heat waves and natural disasters become more frequent, lawmakers are calling for more action against climate change.
‘Barbenheimer’ tops $235 million in domestic debut, eyes second-highest box office weekend ever
“Barbenheimer” exploded over the weekend, generating an estimated $235.5 million in ticket sales and reinvigorating the domestic box office.
American Airlines boosts pilot contract offer by $1 billion after United deal
American Airlines CEO Robert Isom said the airline will match pay rates at rivals.
Oil markets are still volatile, U.S. energy chief says, calling for further supplies
“There’s no doubt that there is a volatile environment,” U.S. Energy Secretary Jennifer Granholm said.
The dollar’s decline is yet another positive for the broad market — including AI stocks
A softer dollar is a boon for the S&P 500 because a large number of companies in the index generate meaningful sales overseas.
Pfizer says no major tornado damage to drug manufacturing areas of North Carolina facility
The pharmaceutical company did not say whether it expected the tornado damage to lead to new drug shortages for sterile injectables.
Sanofi expects infant RSV shot to roll out before respiratory virus season this fall
Sanofi said it is working with a CDC panel to include Beyfortus on the childhood immunization schedule and the Vaccines for Children Program.
Kenvue CEO says consumers are spending on brand-name health products even as they pull back in other areas
Thibaut Mongon’s remarks follow Kenvue’s second-quarter earnings beat, which was fueled by resilient demand for brands like Band-Aid, Tylenol and Aveeno.
